Although glial GABA uptake and release have been studied in vitro, GABA transporters (GATs) have not been characterized in glia in slices. Whole cell patch-clamp recordings were obtained from Bergmann glia in rat cerebellar slices to characterize carrier-mediated GABA influx and efflux. GABA induced inward currents at Ϫ70 mV that could be pharmacologically separated into GABA A receptor and GAT currents. In the presence of GABA A/B/C receptor blockers, mean GABA-induced currents measured Ϫ48 pA at Ϫ70 mV, were inwardly rectifying between Ϫ70 and ϩ50 mV, were inhibited by external Na ϩ removal, and were diminished by reduction of external Cl Ϫ . Nontransportable blockers of GAT-1 (SKF89976-A and NNC-711) and a transportable blocker of all the GAT subtypes (nipecotic acid) reversibly reduced GABA-induced transport currents by 68 and 100%, respectively. A blocker of BGT-1 (betaine) had no effect. SKF89976-A and NNC-711 also suppressed baseline inward currents that likely result from tonic GAT activation by background GABA. The substrate agonists, nipecotic acid and ␤-alanine but not betaine, induced voltage-and Na ϩ -dependent currents. With Na ϩ and GABA inside the patch pipette or intracellular GABA perfusion during the recording, SKF89976-A blocked baseline outward currents that activated at Ϫ60 mV and increased with more depolarized potentials. This carrier-mediated GABA efflux induced a local accumulation of extracellular GABA detected by GABA A receptor activation on the recorded cell. Overall, these results indicate that Bergmann glia express GAT-1 that are activated by ambient GABA. In addition, GAT-1 in glia can work in reverse and release sufficient GABA to activate nearby GABA receptors.
I N T R O D U C T I O N
suggested that glia were capable of removing transmitters such as ␥-aminobutyric acid (GABA) that overflow from the synaptic cleft. This pioneer work on GABA uptake was rapidly followed by a substantial number of studies on the ability of glia to take up GABA in vitro (Iversen and Kelly 1975) . It is now clear that GABA influx into glia and in particular astrocytes is mediated via specific high-affinity transporters (Schousboe and Westergaard 1995) . Four types of high-affinity GABA transporters (GATs), each with a distinct structure, pharmacology, and distribution have recently been cloned. In rat and human, these GATs are named GAT-1, BGT-1, GAT-2, and GAT-3 (Borden et al. , 1995a Guastella et al. 1990 ). Of these, BGT-1 transports both GABA and the osmolyte betaine (Matskevitch et al. 1999) . Prior to the cloning of distinct GATs, based on pharmacological studies it was unclear whether there were distinct GABA-uptake systems in neurons and in glia (Larsson et al. 1988; Smith et al. 1992) . It is now clear that the so-called "neuronal" GATs are expressed in astrocytes both in cultured cells and in brain tissue (Borden 1996; Borden et al. 1995b; Kanner and Bendahan 1990) . Immunoreactivity for GAT-1/2/3 has been reported in astrocytes from different brain regions De Biasi et al. 1998; Minelli et al. 1996; Morara et al. 1996; Ribak et al. 1996; Yan and Ribak 1998) . It has also become evident that astrocytes in brain tissue and in culture express different GAT subtypes (Borden 1996) , thus confounding the extrapolation of data from uptake studies in vitro to the role of glial GATs in intact brain. Thus there is a critical need for characterizing GATs in astrocytes in situ as well as for other transporter and receptor systems (Kimelberg et al. 2000) . While GATs are generally viewed as permitting influx of GABA, they also have the ability to work in reverse depending on internal Na ϩ concentration and membrane depolarization (Cammack and Schwartz 1993; Cammack et al. 1994; Risso et al. 1996) . Although transporter-mediated GABA release has been shown from astrocytes (Gallo et al. 1991; Levi and Gallo 1995; Yee et al. 1998) , the membrane depolarization at which GABA efflux occurs has not been investigated in astrocytes.
To our knowledge, GAT currents have not been characterized in astrocytes in slices. Immunohistochemical studies show that the specialized astrocytes of the cerebellum, the Bergmann glia, possess GAT-1 on their soma and processes (Morara et al. 1996; Swan et al. 1994 ) that encapsulate GABAergic synapses on Purkinje cells (Castejon 1990 ). Thus we ask the two following questions: do Bergmann glia indeed possess functional GATs in slices and in particular the fast transport cycle GAT subtype GAT-1 and can GATs in Bergmann glia work in reverse and mediate GABA efflux? To answer these questions, whole cell patch-clamp recordings were obtained from Bergmann glia in cerebellar slices. In the presence of GABA receptor blockers, every recorded Bergmann glial cell displayed inward currents in response to pressure application of GABA that were Na ϩ and voltage-dependent and sensitive to various GAT blockers. The pharmacological profile of the GABA responses indicates that GAT-1 is expressed in Bergmann glia. Finally, intracellular injection of GABA induces an efflux of GABA that can be detected at and above holding potentials of Ϫ40 mV and activates GABA A receptors.
M E T H O D S

Slice preparation
Cerebellar slices were prepared as previously described (Bordey and Sontheimer 2000; Muller et al. 1994) . Briefly, 15-to 30-day-old Sprague Dawley rats were anesthetized using pentobarbital (50 mg/ kg) and decapitated. A rapid craniotomy that removed the occipital bone and mastoid processes allowed the cerebellum to be quickly detached, removed and chilled (0Ϫ4°C) in 95% O 2 -5% CO 2 saturated artificial cerebrospinal fluid (ACSF) containing (in mM) 125 NaCl, 3 KCl, 2 CaCl 2 , 2 MgCl 2 , 25 NaHCO 3 , and 10 glucose. Next, the cerebellum was glued (cyanoacrylate glue) to the stage of a vibratome and transversal slices (250 m thick) were cut in cold oxygenated ACSF. After a recovery period of at least an hour in ACSF, slices were placed in a flow-through chamber, held in position by a nylon mesh glued to a U-shaped platinum wire, and continuously superfused with oxygenated ACSF at room temperature. The chamber was mounted on the stage of an upright microscope (Olympus BX50) equipped with a ϫ60 water-immersion objective and infrared optics.
Whole cell recordings and drug application
Whole cell patch-clamp recordings were obtained as previously described (Bordey and Sontheimer 2000) . Patch pipettes were pulled from thin-walled borosilicate glass (1.55 mm OD; 1.2 mm ID; WPI, TW150F-40) on a PP-83 puller (Narishige, Japan). Pipettes had resistances of 6 -8 M⍀ when filled with the following solutions (in mM): 140 KCl or 140 CsCl or 134 K-gluconate and 6 KCl when noted; 1.0 CaCl 2 ; 2.0 MgCl 2 ; 10 ethylene glycol-bis-(aminoethyl ether)-N,N,NЈ,NЈ-tetraacetic acid (EGTA); and 10 HEPES. pH was adjusted to 7.2 with NaOH, which introduced Na ϩ at a concentration of 2.5 mM. For some recordings with a KCl-based solution and for all of the recordings with a CsCl-based solution, the intracellular solution containing 3 mM MgATP and 0.2 mM NaGTP was used. Osmolarities of the intracellular and extracellular solutions were 295-300 and 305-310 mosM, respectively. The osmolarity of all solutions was measured with a vapor pressure osmometer 5500 (Wescor) and was adjusted by addition of water or D-mannitol. In some experiments, extracellular Na ϩ was replaced by an equimolar amount of choline or Li ϩ . To test GABA transport reversal, GABA (10 mM) and HEPES-Na (10 mM) replaced equimolar amount of intracellular KCl and HEPES, respectively. When voltage steps were applied to the recorded cell, 5 mM Cs ϩ and 40 mM TEA was added to the extracellular solution in exchange for an equimolar amount of Na ϩ to suppress voltage-activated and time-dependent outward K ϩ currents present in Bergmann glia (Bordey and Sontheimer 2000) . To study the voltage dependence of GAT currents, the cells were gradually depolarized. When recorded with a KCl-based solution, there was a large change in the holding current. In this condition GABA was applied a minimum of 3 min after a 20-mV depolarization to allow for the holding current to stabilize. To suppress synaptic release of GABA, an extracellular solution containing 0 Ca 2ϩ (replaced by MgCl 2 ), 1 mM EGTA, and 1 M TTX was used. In some glial recordings to facilitate reversal of GATs, HEPES sodium salt was used instead of HEPES, and 10 mM GABA replaced an equal amount of KCl or KGluconate. Solutions containing picrotoxin were prepared daily. Usually 15 mg picrotoxin was added to 50 ml extracellular solution and sonicated for approximately 20 min. To label cells for later morphological identification and antigenic identification, 0.1% Lucifer yellow (LY, dilithium salt) was added to the pipette solution. Whole cell recordings were performed using an Axopatch-200B amplifier (Axon Instruments). Current signals were low-pass filtered at 2-5 kHz and digitized on-line at 5-20 kHz using a Digidata 1320 digitizing board (Axon Instruments) interfaced with an IBM-compatible computer system. Data acquisition, storage, and analysis were done using PClamp version 8.0.2 (Axon Instruments). Settings were determined by compensating the transients of a small (5 mV) 10-ms hyperpolar-izing voltage step. The capacitance reading of the amplifier was used as value for the whole cell capacitance. Capacitive and leak conductances were not subtracted. Junction potentials of 4 and 14 mV with a KCl and KGluconate-rich solutions were not corrected. Peak currents were determined using Clampfit (Axon Instruments), and statistical values (mean Ϯ SD, with n being the number of cells tested) were evaluated with a statistical graphing and curve-fitting program (Origin, MicroCal) . Statistical comparison of means was performed with Student's t-test.
Both bath and pressure applications were used. Receptor and transporter inhibitors were diluted in ACSF and applied by a rapid bath application system. Receptor and transporter substrate agonists were pressure applied by a computer-controlled pressure ejection system (2-channel picospritzer, General Valve). They were diluted in ACSF, in which HEPES replaced NaHCO 3 and pH was adjusted to 7.4 by NaOH. When NaCl was replaced by choline or another chemical, similar changes were performed in the pressure pipette solution. The pressure ejection pipettes were standard unpolished patch-electrodes with resistances of 6 -8 M⍀ for local agonist application and were just above the slice. The applied pressure was between 3 and 5 psi. For applying two drugs to the same cell, a theta glass with one distinct drug in each compartment was used.
INTRACELLULAR PERFUSION OF A GABA TRANSPORTER BLOCKER
DURING THE RECORDING. Intracellular perfusion of a GABA transporter blocker was performed as previously reported by others for single or multiple drugs application (Tang et al. 1990 ). We used a straight pipette holder with a perfusion port (EH-U2, E. W. Wright). Through the perfusion port, a polyethylene tube (0.86 mm ID and 1.27 mm OD) was introduced sufficiently far to reach well into the patch pipette solution. A 1-ml syringe containing the LY-filled intracellular solution to be perfused during the recording was connected to the polyethylene tube via an elongated and thinned plastic pipette tip. Before adding the patch pipette, positive pressure was manually applied to fill up the tube all away to the end, remove air bubbles, and visualize efflux of solution. Then, after applying negative pressure to prevent any solution leakage but without adding an air bubble to the end of the tube, the patch pipette was inserted into the holder. To perfuse the LY-filled solution containing either GABA or SKF89976-A, a positive pressure was manually applied to add sufficient solution to double the volume in the patch pipette (about 20 l). The concentrations of GABA and SKF89976-A were double to obtain the intended final concentrations in the cell.
Cell identification
Images of cells visually chosen for recordings were archived using a LG3 frame grabber (Scion) for later (off-line) comparison to LY fills. After recordings, slices were transferred to a fixation medium containing 4% paraformaldehyde in phosphate-buffered saline (PBS). The next day, slices were washed three times in PBS for 1 h, were incubated for 15 min with 1% Triton X-100, 5% normal goat serum (NGS, Sigma) in PBS, and then were incubated for 1 h in the blocking solution 0.2% triton, 5% NGS in PBS. Slices were then incubated with Cy3-conjugated antibody against GFAP (Sigma, dilution on 1:500) for 2 h at room temperature in the blocking solution. Slices were then washed in PBS and mounted on glass coverslips with fluorescent mounting medium (Vectashield, Vector) and were viewed on an Olympus microscope (BX51). Images were captured with a DVC color camera and printed on an Epson color printer. No bleed-through was observed between the Texas red/Cy3 and FITC fluorescence channels in control experiments.
Chemicals were purchased from Sigma (Saint Louis, MO), unless otherwise noted. R E S U L T S Whole cell recordings were obtained from 143 visually identified Bergmann glia in cerebellar slices of 15-to 30-dayold rats. This age period corresponds to the final maturation of inhibitory synapses onto Purkinje cells from basket and stellate cells (Crepel et al. 1981 ). Every recorded cell was filled with LY and identified as a Bergmann glial cell by a typical morphology characterized by a small soma size (8 -12 m) and three or more long, parallel processes extending in the molecular layer toward the pial surface (de Blas 1984; Reichenbach et al. 1995) . Figure 1A shows a representative example of a LY-filled Bergmann glial cell. Recorded cells with such morphology stained positive for glial fibrillary acidic protein (GFAP), identifying them as astrocytes (Eng 1985) ( Fig. 1B ). In addition, cells recorded with KCl-and KGluconate-based intracellular solutions had a characteristically low mean input resistance of 60.4 Ϯ 22.4 (SD) M⍀, (n ϭ 125), a mean hyperpolarized resting membrane potential (V R ) of Ϫ76.9 Ϯ 8.3 mV (n ϭ 125), and lacked current-induced action potentials under current clamp (data not shown). Mean cell capacitance (C m ) was 45.3 Ϯ 18.3 pF (n ϭ 125). Because no significant difference for these parameters was observed between both intracellular solutions, values were pooled. The mean input resistance of the cells recorded in 5 mM Cs/40 mM TEA was 110.8 Ϯ 13.4 M⍀ (n ϭ 17). These values were determined in the first 3 min of whole cell recording.
Bergmann glia possess pharmacologically distinct GABA transporters
GABA ACTIVATES BOTH GABA A RECEPTORS AND TRANSPORTERS.
Bergmann glia were recorded at a holding potential of Ϫ70 mV unless otherwise noted. Pressure applications (puff) of GABA (500 M, 5 s) induced large inward currents of Ϫ585.9 Ϯ 259.0 pA (n ϭ 19, Fig. 1 , Ca and Da). These currents activated within 5 s, decayed to 70% of the peak value while GABA was still present in the bath, and were often accompanied by an increase in noise (Fig. 1 , Ca and Da). Such currents are typical of GABA responses in Bergmann glia (Muller et al. 1994 ) and other astrocytes (Fraser et al. 1997) . To identify the nature of the GABA-induced currents, we bath applied antagonists of GABA receptors (GABARs). Bath application of picrotoxin (PTX, 500 M; Fig. 1Cb ) or bicuculline (250 M, Fig. 1Db ), two blockers of GABA A Rs, reversibly reduced GABA-induced currents by 93.6 Ϯ 4.1%. (n ϭ 29, the percentage block with both blockers was pooled). The residual currents were small in amplitude, did not decrease in amplitude while GABA was still present, and were not accompanied by an increase in noise. Such residual currents were observed in all the tested FIG. 1. GABA activates GABA A receptors and transporters in Bergmann glia in situ. A: photograph of a Lucifer-yellow-filled Bergmann glial cell in a 250 m slice from a 16-day-old rat. B: anti-GFAP antibody labeling superimposed on the cell shown in A. C: a puff of GABA (500 M) induced an inward current (a) reduced by bath application of 500 M picrotoxin (PTX, b), a blocker of GABA A/C receptors. The PTX-insensitive current was not affected by 100 M phaclofen, a blocker of GABA B Rs (c). Recordings were obtained with a KCl-based internal solution. D: a puff of GABA (500 M) induced an inward current (a) reduced by bath application of 250 M bicuculline (b). E: a puff of isoguvacine (500 M) induced an inward current (a) that was completely blocked by bicuculline (b). Recordings in (D and E) were obtained with a CsCl-based internal solution. E and F: the picrotoxin (PTX)-and phaclofen-insensitive current was not affected by 2 mM Ba 2ϩ (F) and 1 M TTX (G). All the recordings were performed from a holding potential of Ϫ70 mV. cells. The PTX-and bicuculline-insensitive GABA-induced currents were unaffected by the GABA B R antagonist phaclofen (100 M; Ϫ50.5 Ϯ 8.2 pA in control and Ϫ51.1 Ϯ 8.0 pA in phaclofen, n ϭ 7; Fig. 1Cc ; data not shown for currents in the presence of bicuculline). For further characterization of GABA-induced inward currents, phaclofen and PTX were routinely applied in the external solution. PTX was used instead of bicuculline because PTX blocks both GABA A R and GABA C R (Bormann and Feigenspan 1995) . PTX-and phaclofen-insensitive GABA currents were not affected by recording Bergmann glia using either a CsCl-based intracellular solution or a KCl-based intracellular solution with ATP ϩ GTP. The mean residual current amplitude was Ϫ47.4 Ϯ 17.9 pA (n ϭ 49/49) and Ϫ46.0 Ϯ 13.7 pA (n ϭ 27/27) without and with ATP ϩ GTP in a KCl-based intracellular solution, respectively (Fig.  1C ). This mean amplitude was similar to the mean current amplitude of Ϫ47.3 Ϯ 7.1 pA (n ϭ 16) when the cells were recorded with a CsCl-based intracellular solution containing ATP (Fig. 1D ). Replacement of CsCl for KCl did not reduce the magnitude of GAT currents, which was expected because K ϩ is not required for GAT activity (Attwell and Mobbs 1994; Cammack and Schwartz 1993) . These GABA-induced currents insensitive to PTX, bicuculline, and phaclofen resemble GAT currents in other cell types in vitro (Dong et al. 1994; Kavanaugh et al. 1992; Risso et al. 1996) , including retinal Müller glia (Biedermann et al. 1994; Zhao et al. 2000) . Puffs of isoguvacine (500 M) induced inward currents that were completely blocked by bicuculline (200 M), showing that GABA A R antagonists are efficient at fully blocking GABA A R activation (n ϭ 3) in our recording conditions (Fig. 1E ). These GABA-induced currents were also unaffected by 2 mM Ba 2ϩ or Cs ϩ (Ϫ51.7 Ϯ 5.2 pA in control and Ϫ53.1 Ϯ 5.7 pA in Ba 2ϩ or Cs ϩ , n ϭ 4, data for Ba 2ϩ and Cs ϩ were pooled; Fig.  1F for Ba 2ϩ , data not shown for Cs ϩ ). This result rules out the possibility that K ϩ , which could be released by surrounding Bergmann glia depolarized by GABA via GATs, generates the current by passing through inwardly rectifying K ϩ channels in the recorded Bergmann glial cell (Bordey and Sontheimer 2000) . In addition, residual GABA-induced currents were unaffected by 1 M tetrodotoxin (TTX, Ϫ49.0 Ϯ 10.8 pA in control and Ϫ49.0 Ϯ 11.2 pA in TTX, n ϭ 3, Fig. 1G ) and an extracellular solution containing 0 Ca 2ϩ /1 mM EGTA (n ϭ 2, data not shown). This result rules out the possibility that glutamate, which could be released following depolarization of presynaptic terminals by GAT activation (Bonanno et al. 1993 ), induces the current by activating receptors on the recorded Bergmann glial cell (Bergles et al. 1997; Feigenspan and Bormann 1994; Muller et al. 1996) .
Every cloned GABA transporter depends on Na ϩ and Cl Ϫ for the uptake of GABA (Borden et al. 11992, 995a; Guastella et al. 1990 ). Figure 2A shows that when choline or Li ϩ was substituted for external Na ϩ (n ϭ 14), PTX-and phaclofeninsensitive GABA currents were reversibly and completely blocked, identifying them as GAT currents. Lowering extracellular Cl Ϫ from 136 to 11 mM (NaCl replaced with Nagluconate) reduced GAT currents by 63.0 Ϯ 7.0% (n ϭ 5) ( Fig.  2B) . A 50% change in extracellular Cl Ϫ concentration did not yield any detectable reduction in GABA-induced GAT currents.
In all the tested cells, GABA induced a transport current. To FIG. 2. Ionic and voltage dependence of PTX-and phaclofen-insensitive GABA currents. A: GABA-induced currents were abolished by replacing external Na ϩ with choline, identifying them as GABA transporter (GAT) currents. B: GABA currents were reversibly diminished by reduction of external Cl Ϫ (11 mM instead of 136 mM). In A and B, recordings were obtained at Ϫ70 mV. C: GABA-induced currents recorded at different holding potentials from Ϫ70 to ϩ50 mV. D: mean I-V curves of GAT currents obtained with KCl (n ϭ 5)-and CsCl-based (n ϭ 3) internal solutions. For all the recordings GABA (500 M) was pressure applied in the presence of PTX (500 M) and phaclofen (100 M). determine whether GAT amplitudes were different before and after the completion of the GABAergic synaptic connections onto Purkinje cells at postnatal day (P) 23 in the rat (Rosina et al. 1999) , we divided our mean GAT current amplitudes into two age groups P15-P22 and P24-P30. Mean GAT current amplitudes were Ϫ45.7 Ϯ 15.2 pA (n ϭ 41) and Ϫ48.6 Ϯ 16.6 pA (n ϭ 26) in cells from P15 to P22 and P24 to P30 rats, respectively. These values were not significantly different.
When we gradually changed the holding potential of the recorded Bergmann glial cell from Ϫ70 to ϩ50 mV, GABAinduced GAT currents decreased progressively in amplitude when recorded with either a KCl-based intracellular solution ( Fig. 2C , n ϭ 5) or a CsCl-based intracellular solution (n ϭ 3, data not shown). The current-voltage (I-V) relationship rectified inwardly and did not reverse for positive membrane potentials (Fig. 2D, Ⅲ and [ ] in KCl-and CsCl-based solutions, respectively, mean Ϯ SE are shown in the graphs). Such I-V curves are expected for GATs under the recording conditions used (Biedermann et al. 1994; Cammack and Schwartz 1993; Dong et al. 1994) . All together these data suggest that GABAinduced currents in the presence of GABA A/B/C R blockers are generated by GABA being taken up into Bergmann glia by GABA transporters. PHARMACOLOGICAL CHARACTERIZATION OF GAT CURRENTS.
Four distinct GATs have been cloned thus far, termed GAT-1, -2, and -3 and BGT-1 in rats. GAT-1 displays a distinct pharmacological profile from the other GATs (Borden et al. , 1995a Guastella et al. 1990 ). We first tested nipecotic acid and ␤-alanine, which are competitive blockers of GAT-1/2/3 subtypes (Krogsgaard-Larsen and Johnston 1975; Liu et al. 1993 ) and GAT-2/3 subtypes Liu et al. 1993) , respectively. Bath application of nipecotic acid (100 M) and ␤-alanine (100 M) induced baseline inward currents that averaged Ϫ51.0 Ϯ 2.2 pA (n ϭ 11/11) and Ϫ26.1 Ϯ 11.0 pA (n ϭ 8/8), respectively, as shown by the deviation of the holding current with the GAT substrate agonist from the control ( Fig. 3, Ab, dashed line) . In the presence of bath-applied ␤-alanine, GABA induced additional inward current (Fig. 3B) . Nipecotic acid and ␤-alanine occluded 100% (n ϭ 11, Fig. 3A ) and 57.1 Ϯ 5.3% (n ϭ 8, Fig. 3B ) of the maximal GABAinduced GAT currents, respectively. GAT currents were unaltered by betaine, a competitive blocker of BGT-1 (Ϫ51.0 Ϯ 9.2 pA in control and Ϫ50.4 Ϯ 9.4 pA with betaine, n ϭ 5; data not shown). We then tested the effects of two specific nontransportable blockers of GAT-1 SKF89976-A and NNC-711 (Borden et al. 1994) . Bath application of SKF89976-A (100 M; Fig. 3D ) and NNC-711 (10 M; Fig. 3C ) reversibly reduced GAT currents in every studied cell by 67.9 Ϯ 4.4% (n ϭ 19; % block by each blocker was similar and data were thus pooled). The reduction of GAT current by ␤-alanine and their incomplete block by GAT-1 blockers suggest that GAT-1 and another GAT subtypes are expressed in Bergmann glia. Interestingly, these GAT-1 blockers induced outward currents in 63% of the tested glia even though these compounds are nontransportable blockers of GAT-1. These outward currents averaged 10.5 Ϯ 2.7 pA (n ϭ 12). This result suggests that SKF89976-A and NNC-711 block an inward current due to either a tonic activation of GATs by ambient levels of GABA and/or a leakage conductance associated with the transporter Schwartz 1993, 1996; Mager et al. 1996) . Such a leakage conductance has been observed in the absence of GABA, and the current is carried by Na ϩ ions. To help distinguish between these two possibilities, we used an extracellular solution containing 0 Ca 2ϩ /1 mM EGTA/1 M TTX to prevent synaptic Ca 2ϩ -dependent GABA release and thus reduce levels of background GABA. In this condition, SKF89976-A applied by pressure ( Fig. 7A before intracellular GABA perfusion) or perfused intracellularly (Fig. 7B ) never induced any current in Bergmann glia (n ϭ 6).
To further characterize GAT currents in Bergmann glia, we pressure applied different substrate agonists and studied the Na ϩ and voltage dependence of the resulting currents. GABA and a substrate agonist (each 500 M) were applied in succession on the same cell using a theta glass pressure pipette. The mean inward currents induced by nipecotic acid and GABA were not significantly different (P ϭ 0.02) and averaged Ϫ42.9 Ϯ 7.1 and Ϫ50.8 Ϯ 4.7 pA, respectively (n ϭ 8/8, Fig. 4A) . Similarly, mean inward currents induced by ␤-alanine and GABA were not significantly different and averaged Ϫ47.4 Ϯ 5.8 and Ϫ51.6 Ϯ 7.0 pA (n ϭ 4/4), respectively (Fig. 4B) . ␤-alanine was pressure applied in the presence of bath-applied taurine (100 M) to block taurine transporters because ␤-alanine is also a substrate agonist of taurine transporters (Liu et al. 1992; Smith et al. 1992) . A puff of betaine did not induce any inward currents (n ϭ 11, Fig. 4C ). When Na ϩ was replaced by choline, currents induced by nipecotic acid (Fig. 4A, n ϭ 3) and ␤-alanine (Fig. 4B, n ϭ 3) were reversibly blocked, suggesting that both substrate agonists induced transport currents. Consistent with this idea we found that in the absence of PTX, nipecotic acid-and ␤-alanine-induced currents were not affected by the subsequent application of PTX (n ϭ 5, data not shown). The voltage dependence of ␤-alanineand GABAinduced GAT currents was similar (Figs. 5B and 2C, respectively). ␤-alanine-induced currents were strictly inwardly rectifying up to ϩ50 mV (Fig. 5D ). In contrast nipecotic acidinduced inward currents were followed by outward currents that are detectable at and above Ϫ30 mV [ Fig. 5A , see outward currents above baseline (⅐ ⅐ ⅐)]. Only outward currents were observed at ϩ30 and ϩ50 mV (Fig. 5, A and C) . We questioned whether the outward currents following nipecotic acidinduced inward currents could be explained by nipecotic acidinduced heteroexchange of GABA pressure applied onto the same cell (data not shown). To support the interpretation of nipecotic acid-induced GABA heteroexchange, slices were incubated with increasing concentrations of bath applied GABA prior to pressure applications of nipecotic acid. When the cells were held at Ϫ30 mV, outward currents following nipecotic acid-induced inward currents were detectable (n ϭ 3, Fig. 5E ). In addition, the amplitude of these outward currents was dependent on the concentration of bath-applied GABA (Fig. 5, E  and F) . Together these data demonstrate the presence of functional GAT-1 in Bergmann glia in situ.
GAT-mediated GABA efflux from Bergmann glia
For all of the following experiments, seal and whole cell recordings were performed initially in a normal external solution and subsequently, in an external solution containing 0 Ca 2ϩ /1 mM EGTA/1 M TTX, to block Ca 2ϩ -dependent neuronal GABA efflux. TEA (40 mM)/5 mM Cs ϩ /100 M phaclofen was also bath applied to block K ϩ currents and GABA B R activation.
GATS CAN WORK IN REVERSE IN BERGMANN GLIA RECORDED
WITH 10 mM INTRACELLULAR GABA. Bergmann glia were held at Ϫ20 mV and recorded with a KCl-based intracellular solution (isotonic Cl Ϫ ) containing 10 mM GABA and 12.5 mM [Na ϩ ]. In the presence of PTX, a puff of SKF89976-A (500 M) induced a mean inward current of Ϫ17.3 Ϯ 3.5 pA (n ϭ 5/5, Fig. 6A ), suggesting that SKF89976-A blocked an outward current due to transport reversal at Ϫ20 mV. SKF89976-Asensitive currents were not observed between Ϫ60 and Ϫ40 mV, were outward at Ϫ20 mV and up, and increased in amplitude when the cell was further depolarized (Fig. 6B, ࡗ) . These data suggest that GAT-1 can work in reverse. However, to verify that GABA efflux was accompanied Na ϩ efflux, we wonder whether GABA could activate GABA A R on the same cells. We thus repeated the same experiments in the absence of extracellular PTX. In this condition, a puff of SKF89976-A (500 M) induced a smaller mean inward current that was Ϫ9.0 Ϯ 2.6 pA in amplitude (n ϭ 3 of 5 cells, Fig. 6B ). In this condition (symmetrical Cl Ϫ concentrations), GABA A R-medi-ated currents are inward at Ϫ20 mV and likely reduce the apparent amplitude of outward GAT currents. In addition, at depolarized potentials, it is likely that GABA A Rs are desensitized because of carrier-mediated GABA efflux and ambient GABA accumulation. GABA A R desensitization would explain the lack of effect of PTX on outward currents at depolarized potentials. Together these results suggest that GABA A Rs is activated by GABA released via depolarization-induced transport reversal. ACTIVATION OF GABA A RS ON GABA TRANSPORT REVERSAL. In the following experiments, we intracellularly perfuse GABA during the recording. Intracellular GABA and Na ϩ concentrations were then about 10 and 12.5 mM, respectively (see METHODS). In addition, we recorded cells with a K-gluconate intracellular solution to impose a Nernst equilibrium potential for Cl Ϫ ions at Ϫ61 mV (intracellular Cl Ϫ concentration of 12 mM). In this condition, GABA A R-mediated currents were outward at and above Ϫ60 mV like transport reversal-mediated currents. GABA-and isoguvacine-induced currents reversed at Ϫ61.4 Ϯ 7.3 mV (n ϭ 8; range Ϫ53 to Ϫ70 mV; because no significant difference was observed between the agonists values were pooled). On intracellular perfusion of GABA in FIG. 6. SKF89976-A-sensitive baseline reverse transport current. Bergmann glia were recorded with an internal solution containing GABA and Na ϩ at 10 mM each and in the presence of PTX, phaclofen, 0 Ca 2ϩ /1 mM EGTA/1 M TTX/40 mM TEA/5 mM Cs ϩ in the bath. A: SKF89976-A-induced inward currents recorded at different holding potentials. These inward currents resulted from the blockade of baseline currents from the reverse transport of GABA. B: I-V curves of the outward current blocked by SKF89976-A with (}) and without (ᮀ) 500 M PTX. SKF89976-A was pressure applied at 500 M.
Bergmann glia recorded at Ϫ20 mV, an outward current of 22.7 Ϯ 3.9 pA (n ϭ 4) developed (Fig. 7) . These outward currents were reversibly reduced by a puff of SKF89976-A (500 M, n ϭ 4, Fig. 7A ) or bicuculline (200 M, n ϭ 4, data not shown). The initial decrease in the outward current amplitude ( Fig. 7A, large arrow) observed approximately 20 s after the current onset may be due to GABA A R desensitization as suggested in Fig. 6 . On intracellular perfusion of a LY-filled solution without Na ϩ or GABA, a puff of SKF89976-A or bicuculline did not induce any current (n ϭ 8). LY was routinely added in the intracellularly perfused solution but not in the recording solution to confirm that the perfused solution was diffusing into the cell. LY did diffuse into the cell in all experiments of this type (data not shown). We used an additional control to verify that the intracellularly perfused drug was being effectively perfused inside the recorded cell. Intracellular perfusion of 20 M SKF89976-A progressively re-duced and blocked GABA-induced GAT currents without blocking GABA A R-mediated currents (n ϭ 4, Fig. 7B ).
To prevent GABA A R desensitization due to GABA efflux and ambient GABA accumulation, we studied GABA effluxmediated GABA A R activation by applying 150-ms voltage steps. Voltage steps (20-mV increment) were applied from Ϫ100 to ϩ40 mV from a holding potential of Ϫ70 mV. In response to voltage steps, Bergmann glia generated transient (capacitive) and small steady-state currents (Fig. 8A) . These voltage steps were applied before and after the following successive experimental conditions: intracellular perfusion of GABA during the recording (Fig. 8A) , bath application of PTX to block GABA A Rs activated by GABA efflux (Fig. 8B) , and after washout of PTX bath application of SKF89976-A to block GAT-1 and thus to block GABA efflux and GABA A R activation (Fig. 8C) . The action of each drug is summarized in Fig. 8I . Intracellular perfusion of GABA (see previous paragraph) induced an increase in the steady-state currents without affecting capacitive currents (Fig. 8B, compare with A) . Pointby-point subtraction of the currents in the presence and absence of intracellular GABA isolated outward currents that averaged 23.3 Ϯ 6.0 pA at Ϫ20 mV (n ϭ 5, Fig. 8E ). This mean amplitude is similar to that of the outward currents obtained on intracellular GABA perfusion in cells held at Ϫ20 mV (Fig.  7A) . The I-V curves of these currents show that they are voltage-dependent and outwardly rectifying, appear near Ϫ60 mV, and could be clearly detected at Ϫ40 mV (Fig. 8E, right) . Subsequent bath application of PTX (10 M) induced a decrease in the steady-state outward currents (Fig. 8C) . The subtracted currents (traces with PTX from traces without PTX) isolated PTX-sensitive currents that represent GABA A R-mediated outward currents and averaged 11.9 Ϯ 4.2 pA at Ϫ20 mV (n ϭ 4, Fig. 8F ). The GABA A R-mediated currents were outward at Ϫ20 mV as expected in our intracellular recording conditions imposing an E Cl-of Ϫ61 mV (internal [Cl Ϫ ] of 12 mM). Subtracting the control traces (Fig. 8A , no internal GABA) from the traces with internal GABA and PTX in the bath (Fig. 8C ) isolated transporter-mediated outward currents that averaged 11.6 Ϯ 1.7 pA at Ϫ20 mV (n ϭ 4, Fig. 8G ). The outward current induced by intracellular GABA perfusion (Fig.  8E) is thus composed of transport-and receptor-mediated currents, and each represents 50% of the total outward current in our recording conditions. The I-V curves of receptor-and transporter-mediated outward currents show that they are voltage-dependent and outwardly rectifying and can be clearly detected at Ϫ40 mV (Fig. 8F, right) . Similarly, subsequent application of SKF89976-A after washing out PTX also reduced steady-state outward currents (Fig. 8D) . SKF-89976-A-FIG. 7. Intracellular GABA perfusion during the recording to study GABA transport reversal. A: recorded cells were held at Ϫ20 mV to allow GABA transport reversal. GABA (20 mM) was intracellularly perfused during the recording as indicated by the arrow. Before intracellular GABA perfusion SKF89976-A did not affect baseline currents. After intracellular GABA perfusion, an outward current developed that displayed a transient peak of 40 pA (as shown by a thick head) and then plateau at about 25-30 pA. This outward current was reduced by pressure application of 500 M SKF89976-A. B: 500 M GABA was pressure applied from a holding potential of Ϫ70 mV under different conditions: in the absence of PTX, in the presence of 500 M PTX as indicated by the bar, following the intracellular perfusion of 20 M SKF89976-A as indicated by the arrow, and after washout of PTX. Intracellular perfusion of SKF89976-A resulted in a progressive reduction of GAT currents. Experiments were performed in the presence of phaclofen and 0 Ca 2ϩ /1 mM EGTA/1 M TTX/40 mM TEA/5 mM Cs ϩ . Bergmann glia were recorded with a K-gluconate-based intracellular solution to set the reversal Cl Ϫ potential at Ϫ60 mV.
FIG. 8. Voltage step records for GABA efflux and GABA A R activation. A-D: current traces following 20-mV increment voltage steps of 150 ms applied from Ϫ100 to ϩ40 mV from a holding potential of Ϫ70 mV under control conditions (A) and after intracellular perfusion of 20 mM GABA (B). Following intracellular GABA perfusion, the cells were recorded in the presence of PTX (C) and SKF89976-A (D) following washout of PTX. E: traces in A were subtracted from traces in B to reveal GABA efflux currents and their respective I-V curve (right). F: traces in C were subtracted from traces in B to reveal GABA A R-mediated currents and their respective I-V curve. G: traces in C were subtracted from traces in A to reveal GAT-mediated efflux currents and their respective I-V curve. H: traces in D were subtracted from traces in B to reveal currents due GAT-1 mediated GABA efflux and their respective I-V curve. Experiments were performed in the presence of phaclofen and 0 Ca 2ϩ /1 mM EGTA/1 M TTX/40 mM TEA/5 mM Cs ϩ . Bergmann glia were recorded with a K-gluconate-based intracellular solution. I: scheme describing GABA efflux and the resulting GABA A R activation on the recorded cell. On intracellular perfusion of GABA, GABA leaves the cell via GAT-1 reversal and activates GABA A Rs. Both actions generate outward GABA currents displayed in E. Part of these outward GABA currents are PTX sensitive [GABA A R-mediated (F)] and PTX insensitive (G), which represent GABA efflux currents via GAT reversal. SKF89976-A blocks currents mediated by GAT-1 transporter reversal and the currents due to GABA A R activation. sensitive currents that represent GAT-1 transport reversal-and GABA A R-mediated currents averaged 19.9 Ϯ 8.4 pA at Ϫ20 mV (n ϭ 4, Fig. 8H ). Before intracellular perfusion of GABA, bath application of PTX did not affect the steady-state currents (n ϭ 3; data not shown), demonstrating that PTX did not have a nonspecific action. These data suggest that PTX-sensitive currents are due to GABA transport reversal-mediated GABA efflux that activates GABA A Rs on the recorded Bergmann glial cell.
Because of the nonideal electrical properties of Bergmann glia due to their extensive processes and low input resistance, we obtained recordings of GAT currents from glial cell body that had been pulled out from the slice. This procedure will allow us to more accurately determine the threshold activation of carrier-mediated efflux current. Once Bergmann glia were recorded, their cell body was pulled out of the slice. Two or three very short processes of about 4 -6 m each stayed attached to the soma. In this condition, the mean cell membrane capacitance was 18.7 Ϯ 3.6 pF (n ϭ 4) and the mean cell input resistance was 220.8 Ϯ 27.0 M⍀. We monitored GAT reversal by applying voltage steps as described for Fig. 8 . Voltage steps were applied every 10 mV instead of 20 mV with GABA in the recording pipette instead of being intracellular perfused during the recording. In three of four cells, we observed SKF80076-A-sensitive outward currents (Fig. 9D ) that activated at Ϫ60 mV and were clearly detectable at Ϫ50 mV with a mean value of 15.6 Ϯ 0.8 pA (Fig. 9E ).
D I S C U S S I O N
In the present study, we report for the first time direct measurements of GABA transporter currents in an intact system and electrophysiological characterization of these currents in Bergmann glia. In particular, our data show that Bergmann glia in situ possess functional GABA transporters in particular GAT-1 that are likely activated by ambient levels of extracel-lular GABA and Bergmann glial GABA transporters can mediate electrogenic GABA efflux that results in the activation of nearby GABA A receptors.
Bergmann glia express multiple and functional GABA transporter subtypes ISOLATION OF FUNCTIONAL GATS IN BERGMANN GLIA. Our data showed that a large portion of GABA-induced currents were sensitive to PTX and bicuculline and thus mediated by GABA A R and perhaps GABA C R activation. GABA A R properties in Bergmann glia were characterized in a previous report (Muller et al. 1994 ) and were not further analyzed in the present study. In the presence of blockers for all GABARs, GABA-induced currents were blocked by removal of external Na ϩ , identifying them as currents due to GAT activation (Borden 1996) . The lack of difference between GAT current amplitudes before and after the GABAergic network completion suggests that Bergmann glia express GAT-1 earlier than the completion of the synaptic connections onto Purkinje cells. However, we cannot rule out that there may be a spatial redistribution of GATs on the glial membrane. These GAT currents were also dependent on external Cl Ϫ concentration and voltage as previously reported (Borden 1996) . In the absence of internal GABA and Na ϩ , no outward currents could be detected at depolarized potentials as reported from studies on GAT-1 expressed in oocytes (Kavanaugh et al. 1992; Mager et al. 1993 ) and on GATs in retinal horizontal cells (Cammack and Schwartz 1993; Dong et al. 1994) and Müller glia (Biedermann et al. 1994; Zhao et al. 2000) in vitro. In addition, a 0 current was obtained at and above ϩ30 mV. The uptake of one molecule of GABA is coupled to the uptake of two Na ϩ and one Cl Ϫ ions into the cell. The concentrations of GABA and cotransported ions and the stoichiometry of GATs determine the reversal potential of GAT currents. To predict the reversal potential of GAT currents assuming the standard stoichiometry for GATs, the following simple transport model has been used:
FIG. 9. Voltage step records for GABA efflux recorded in the soma. A-C: current traces following 10-mV increment voltage steps of 150 ms applied from Ϫ100 to Ϫ20 mV from a holding potential of Ϫ70 mV. The cells were recorded with an internal solution containing GABA ϩ Na ϩ each at 10 mM. The cells were recorded under control conditions (A), in the presence of SKF89976-A (B), and following wash out of SKF89976-A (C). D: traces in B were subtracted from traces in A to reveal GAT-1 transport reversal-mediated currents. E: I-V curve of traces in D.
with k and T their usual thermodynamic meanings and q ϭ (z GABA ϩ 2z Na ϩ z Cl )e ϭ e. kT/e is approximately 25 mV at 22°C (Furuta et al. 1997) . Based on this equation and in our recordings conditions (no internal GABA), the I-V curve should be asymptotic and never reverses as observed in the present study. Interestingly in similar recording conditions, GABA-induced outward GAT currents have been observed at depolarized potentials for GAT-1 transfected in HeLa cells (Risso et al. 1996) . Because outward GAT currents were only observed after applying negative potentials to the cell, the authors suggested that negative potentials drive both GABA and Na ϩ into the cell; this then leads to electrogenic efflux through GATs at positive voltages In the present study assuming that an equilibrium for GABA is reached after transporting extracellularly applied GABA inside the cell, the predicted E rev should be determined with the preceding equation included only [Na ϩ ] and [Cl Ϫ ]. This gives an E rev of approximately 200 mV. Because of the small GAT current amplitudes, these currents likely become undetectable at and above ϩ30 mV in our recording conditions although GABA may still be transported inside the cell. In addition, the equation only provides an estimation of E rev because the transport model equation may not be applicable to GABA transporters, which they operate asymmetrically and with variable stoichiometry (Cammack et al. 1994) . In our study, nipecotic acid-induced inward currents were, however, followed by outward currents. Because the presence and the amplitude of nipecotic acid-induced outward currents depend on the preloading of the cell with different GABA concentrations, these currents are likely due to the ability of nipecotic acid to induce GABA heteroexchange (Solis and Nicoll 1992) . BERGMANN GLIA POSSESS FUNCTIONAL GAT-1 AND POSSIBLY SOME UNIDENTIFIED GAT ISOFORMS. A 68% reduction of GABA-induced transport currents by SKF89976-A and NNC-711, two nontransportable blockers of GAT-1, demonstrate that Bergmann glia express GAT-1. This result is consistent with positive immunostaining for GAT-1 and the presence of mRNA for GAT-1 in Bergmann glia (Morara et al. 1996; Swan et al. 1994) . GABA-induced transport currents were also reduced by ␤-alanine, a competitive blocker of GAT-2 and -3 Liu et al. 1993 ). ␤-alanine, which is a substrate agonist of these two transporter subtypes, induced Na ϩ -dependent transporter currents. These currents persisted in the presence of 500 M SKF89976-A (data not shown), suggesting that Bergmann glia express GAT-2 and/or GAT-3. However, because of the lack of a nontransportable blocker of GAT-2/-3 and the absence of detectable GAT-2 and -3 mRNA and GAT-3 immunostaining in the cerebellar molecular layer (Ikegaki et al. 1994; Voutsinos et al. 1998) , we cannot conclude that GAT-2/-3 are present in Bergmann glia. Nonetheless an incomplete block of GAT currents by GAT-1 blockers suggests that some unidentified but functional GAT isoforms might be co-expressed in Bergmann glia. Bath application of betaine, a transportable blocker of BGT-1, did not affect GABA-induced transport currents and did not induce any inward current. This suggests that Bergmann glia do not express BGT-1 during the postnatal period studied. Consistent with the absence of BGT-1, nipecotic acid, which is a competitive blocker of GAT-1, -2, and -3, completely blocked GABAinduced transport currents. Together, these data prove that Bergmann glia express functional GAT-1 but not BGT-1 and suggest that they co-express some unidentified GAT isoforms. ARE GLIAL GATS ACTIVATED BY BACKGROUND GABA? SKF89976-A blockade of a basal inward current suggests either tonic activation of GAT-1 by ambient GABA or an uncoupled (leakage) current associated with the transporters in the absence of GABA Schwartz 1993, 1996; Cammack et al. 1994) . The action of SKF89976-A on baseline currents is likely due to tonic activation of GATs by ambient GABA for two reasons: SKF89976-A did not have any effect when applied in an extracellular solution containing 0 Ca 2ϩ /1 mM EGTA/1 M TTX to prevent synaptic release of GABA and GABA can reach 10 -100 M at the synaptic cleft (Kamermans and Werblin 1992), which is sufficient to activate nearby GATs known to have a high affinity for GABA (EC 50 of 4.7-7 M for GAT-1) (Guastella et al. 1990; Kavanaugh et al. 1992) . The possibility that an undetectable leakage current was also present cannot be excluded.
Glial GATs can mediate electrogenic GABA efflux
To study GABA transport reversal, we either recorded cells with a pipette containing internal GABA and Na ϩ or we perfused GABA ϩ Na ϩ intracellularly during recordings to obtain a final concentration of 10 mM GABA and 12.5 mM Na ϩ . In both conditions, pressure application of SKF89976-A blocked an outward current of about 20 pA at Ϫ20 mV. An uncoupled Na ϩ leakage current through GATs has been reported in the absence of GABA due to a channel mode of the transporters Schwartz 1993, 1996) . Because we used a high GABA concentration of 10 mM that is thought to prevent this leakage current (Cammack and Schwartz 1993) , it is unlikely that the SKF89976-A-mediated outward current blockade results from the blockade of an uncoupled leakage current. Thus these data suggest that GATs were working in reverse on internal (GABA ϩ Na ϩ ) perfusion and glial cell depolarization. However, to ensure that GABA was indeed released, we verified whether adjacent GABA A Rs on the recorded cell were activated during GABA transport reversal. To obtain I-V curves of carrier-mediated GABA efflux, we studied GABA transport reversal by applying voltage steps. This protocol also prevented GABA A R desensitization that might have occurred following extracellular GABA accumulation with the cell held at depolarized potentials. The I-V curve of intracellular GABA-induced outward currents showed that these currents were voltage-dependent and outwardly rectifying, activated near Ϫ60 mV, and were clearly detectable at Ϫ50 mV ( Fig. 9 ). Intracellular GABA-induced outward currents were also reduced by SKF89976-A and PTX. These data confirm that transporter-mediated GABA efflux on Bergmann glial cell depolarization activated GABA A Rs upon the recorded cell. As expected for GABA A R and GAT activation, PTX-and SKF89976-A-sensitive-currents were voltage-dependent and increased in amplitude when the cell was depolarized (equilibrium potential for Cl Ϫ being Ϫ61 mV). We did not observe any GABA A R-mediated inward currents at or less than Ϫ60 mV. This result is consistent with the absence of GABA efflux at hyperpolarized potentials. I-V curves also show that sufficient GABA was released above Ϫ60 mV to activate nearby GABA A Rs. The observation of transporter-mediated GABA efflux is in good agreement with Schwartz's study on retinal neurons in vitro (Schwartz 1987) . Schwartz could detect transporter-mediated GABA efflux currents at Ϫ60 mV, and such currents measured about 20 pA at Ϫ20 mV and were outwardly rectifying.
Could GABA transporters work in reverse under physiological conditions?
A 12.5 mM concentration of intracellular Na ϩ is near physiological because astrocytes have been shown to have about 11-16 mM intracellular Na ϩ in vitro (Rose and Ransom 1996) . Regarding intracellular GABA concentration, astrocytes are thought to contain very little endogenous GABA and to quickly metabolize labeled exogenous GABA (Bardakdjian et al. 1979 ). However, immunoreactivity for GABA has been observed in Bergmann glia (Benagiano et al. 2000) . Glial GABA can be synthesized by two pathways, one from glutamate via glutamate acid decarboxylase present in Bergmann glia (Martinez-Rodriguez et al. 1993 ) and the other from putrescine via diamine oxidase observed in astrocytes from other brain regions (Laschet et al. 1992; Seiler et al. 1979) . Consistent with this idea, it has been reported that astrocytes can synthesize and secrete GABA (Albrecht et al. 1998; Bowery et al. 1975; Pearce and Dutton 1981; Yee et al. 1998) . In particular, peripheral glial cells and astrocytes surrounding the optic nerve have been reported to have sufficient GABA to release and subsequently activate receptors on neurons (Bowery et al. 1975; Yee et al. 1998 ). Thus far our results show that GAT-1 can mediate GABA efflux from Bergmann glia under nearphysiological ionic conditions. One of the next intriguing questions is whether Bergmann glia have sufficient GABA either newly taken up or endogenously synthesized in their thin processes to release and activate nearby receptors.
Functional implications of GABA transporters in Bergmann glia
Arguments in favor of a role of glial GABA transporter on synaptic activity come from previous studies: Bergmann glia have been shown to possess GAT-1 on their radial processes ensheathing Purkinje cell somata and dendrites (Morara et al. 1996; Swan et al. 1994) ; the estimated cycle time of GAT-1 has been reported to be 10 ms, which is near the decay time of GABA A synaptic currents and its affinity for GABA (5-10 M) could control the time course of transmission near GABA A Rs (half-maximal concentration estimated at 10 -100 M) (Kamermans and Werblin 1992; Mager et al. 1993) ; and previous studies have shown that ␤-alanine, which inhibits GAT-2 and -3 that are primarily expressed in astrocytes (Borden 1996) , affects GABAergic synaptic activity in hippocampal slices (Draguhn and Heinemann 1996) and neuronal GABA responses in cervical ganglia (Bowery et al. 1975) . These results suggest that both neuronal and also glial GATs have the ability to contribute to the removal of GABA from synaptic clefts. The next step would be to determine the relative contribution of GATs in glia or neurons to the removal of synaptic GABA. It is also interesting to note that distinct GABA transporter subtypes that have different affinities for GABA (Borden 1996) would allow GABA concentrations in the extracellular space to be spatially modulated by glia.
Overall, our study that characterizes GABA transport in Bergmann glia in situ is an important step in defining the role of GABA transporters in a neuroglial network.
